146
Participants
Start Date
May 6, 2022
Primary Completion Date
February 28, 2026
Study Completion Date
September 30, 2027
BGB-16673
Orally administered
RECRUITING
Peking University Third Hospital, Beijing
RECRUITING
Beijing Chao Yang Hospital,Capital Medical University, Beijing
RECRUITING
Affiliated Zhongshan Hospital of Dalian University, Dalian
RECRUITING
The First Hospital of Jilin University, Changchun
RECRUITING
Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai
RECRUITING
Jiangsu Province Hospital, Nanjing
RECRUITING
The First Affiliated Hospital of Soochow University, Suzhou
RECRUITING
Anhui Provincial Hospital, Hefei
RECRUITING
The First Affiliated Hospital of Bengbu Medical University, Bengbu
RECRUITING
Shandong Cancer Hospital, Jinan
RECRUITING
Qingdao Central Hospital, Qingdao
RECRUITING
Institute of Hematology and Hospital of Blood Disease, Tianjin
RECRUITING
The First Affiliated Hospital, Zhejiang University School of Medicine Branch Yuhang, Hangzhou
RECRUITING
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
RECRUITING
The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang
RECRUITING
Jiangxi Province Cancer Hospital, Nanchang
RECRUITING
Fujian Medical University Union Hospital, Fuzhou
RECRUITING
Second Affiliated Hospital of Army Medical University (Xinqiao Hospital), Chongqing
RECRUITING
The Second Xiangya Hospital of Central South University, Changsha
RECRUITING
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan
RECRUITING
Xiangyang Central Hospital, Xiangyang
RECRUITING
Henan Cancer Hospital, Zhengzhou
RECRUITING
Nanyang Central Hospital, Nanyang
RECRUITING
Sun Yat Sen University Cancer Center, Guangzhou
RECRUITING
Guangdong Provincial Peoples Hospital Huifu Branch, Guangzhou
RECRUITING
The Peoples Hospital of Guangxi Zhuang Autonomous Region, Nanning
RECRUITING
West China Hospital, Sichuan University, Chengdu
RECRUITING
First Affiliated Hospital of Kunming Medical University, Kunming
RECRUITING
Shanxi Provincial Cancer Hospital, Taiyuan
Lead Sponsor
BeiGene
INDUSTRY